Immucell (ICCC) Cash & Equivalents Growth (3y) (2013 - 2026)
Powered by 
Analysis
Immucell (ICCC) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 14.02% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -4.92% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 13.03% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 14.16% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 82.64% |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | 73.01% |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 777.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.64% |
| Dec 31, 2025 | -13.05% |
| Sep 30, 2025 | -23.93% |
| Jun 30, 2025 | -18.41% |
| Mar 31, 2025 | -26.99% |
| Dec 31, 2024 | -28.28% |
| Sep 30, 2024 | -28.67% |
| Jun 30, 2024 | -50.17% |
| Mar 31, 2024 | -47.94% |
| Dec 31, 2023 | -47.97% |
| Sep 30, 2023 | -30.44% |
| Jun 30, 2023 | -43.80% |
| Mar 31, 2023 | -23.81% |
| Dec 31, 2022 | -12.93% |
| Sep 30, 2022 | 55.35% |
| Jun 30, 2022 | 104.25% |
| Mar 31, 2022 | 3.74% |
| Dec 31, 2021 | 59.27% |
| Sep 30, 2021 | 63.68% |
| Jun 30, 2021 | 62.05% |